Castleview Partners’s Carter's CRI Stock Holding History

Castleview Partners’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-844	Closed	-$77K	–	768
2022 Q1	$77K	Buy	+844	New	+$79.3K	0.05%	283

Other funds holding CRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Castleview Partners's CRI Position: Q2 2022 in Review

Castleview Partners sold out of Carter's (CRI) in Q2 2022, closing a stake of 844 shares — an estimated $77K sold.

Castleview Partners first reported a position in CRI in Q1 2022 and held it in 1 quarter. The position peaked at $77K in Q1 2022. 315 funds tracked by Wall St. Rank hold CRI as of Q2 2022.

Castleview Partners reported no remaining Carter's position as of Q2 2022 after selling out during the quarter.
Castleview Partners sold 844 Carter's shares in Q2 2022, an estimated $77K.
Castleview Partners first reported a position in Carter's in Q1 2022 and held it in 1 quarter.
Castleview Partners's Carter's position peaked at $77K in Q1 2022.
315 funds tracked by Wall St. Rank held Carter's as of Q2 2022.

Based on Castleview Partners's 13F filing for Q2 2022, filed 16 Aug 2022.